See the DrugPatentWatch profile for airduo
What is AirDuo?
AirDuo is a medication used to treat asthma and is available in the form of an inhaler. It is a combination of fluticasone and vilanterol, a corticosteroid and a long-acting bronchodilator, respectively [1].
How does AirDuo work?
AirDuo is designed to control asthma symptoms by reducing inflammation and opening up the airways. Fluticasone works by reducing inflammation in the lungs, while vilanterol works by relaxing the smooth muscles in the airways, allowing for easier breathing [1].
Differences between inhalers
AirDuo is different from other inhalers in that it is a combination medication. While other inhalers, such as Advair (fluticasone and salmeterol), contain similar components, the combination of fluticasone and vilanterol in AirDuo is unique [1].
Benefits and risks of using AirDuo
The benefits of AirDuo include improved lung function and a reduction in asthma symptoms. However, like all medications, it also carries risks, such as increased risk of pneumonia and cardiovascular events [1].
Who makes AirDuo?
AirDuo is manufactured by GlaxoSmithKline. The company offers a range of asthma medications, including inhalers and oral medications [2].
When does the patent expire?
The patent for AirDuo expires in 2025 [3].
Is AirDuo available as a generic?
Currently, AirDuo is not available as a generic medication. However, once the patent expires, generic versions of the medication are likely to become available [4].
Sources:
[1] DrugPatentWatch.com - AirDuo DPI (https://www.drugpatentwatch.com/drugs/AirDuo-DPI)
[2] GlaxoSmithKline (https://www.gsk.com/en-gb/)
[3] Patent expiration for AirDuo (https://www.drugpatentwatch.com/patents/US-10284417-B2)
[4] Generic versions of AirDuo (https://www.drugpatentwatch.com/generics/AirDuo-DPI)